Literature DB >> 18308256

Systemic chemotherapy for cancer: from weapon to treatment.

Heikki Joensuu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18308256     DOI： 10.1016/S1470-2045(08)70075-5

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  15 in total

1.  Conditionally replicative adenovirus-based mda-7/IL-24 expression enhances sensitivity of colon cancer cells to 5-fluorouracil and doxorubicin.

Authors:  Jing Xu; Yiwo Mo; Xiaoyun Wang; Jun Liu; Xinjin Zhang; Junfeng Wang; Lei Hu; Chao Yang; Lei Chen; Yankun Wang
Journal:  J Gastroenterol       Date:  2012-07-21       Impact factor: 7.527

2.  Quantitative characterization of the microstructure and transport properties of biopolymer networks.

Authors:  Yang Jiao; Salvatore Torquato
Journal:  Phys Biol       Date:  2012-06-08       Impact factor: 2.583

3.  Tumor specific cytotoxicity of arctigenin isolated from herbal plant Arctium lappa L.

Authors:  Siti Susanti; Hironori Iwasaki; Yukiyoshi Itokazu; Mariko Nago; Naoyuki Taira; Seikoh Saitoh; Hirosuke Oku
Journal:  J Nat Med       Date:  2012-02-16       Impact factor: 2.343

4.  Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.

Authors:  Yan-Shuang Li; Qing Yang; Ming Qi; Ji-Yu Li
Journal:  Mol Clin Oncol       Date:  2017-07-28

5.  Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.

Authors:  Akinobu Kamei; Geli Gao; Geoffrey Neale; Lip Nam Loh; Peter Vogel; Paul G Thomas; Elaine I Tuomanen; Peter J Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

6.  Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide.

Authors:  Monir Moradzadeh Khiavi; Ahamd Rostami; Hamed Hamishekar; Mehran Mesgari Abassi; Amirala Aghbali; Roya Salehi; Bita Abdollahi; Soheila Fotoohi; Mahmud Sina
Journal:  Adv Pharm Bull       Date:  2015-06-01

Review 7.  Next-generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity.

Authors:  Daniel V T Catenacci
Journal:  Mol Oncol       Date:  2014-10-18       Impact factor: 6.603

Review 8.  Leczyme: a new candidate drug for cancer therapy.

Authors:  Takeo Tatsuta; Shigeki Sugawara; Kohta Takahashi; Yukiko Ogawa; Masahiro Hosono; Kazuo Nitta
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

9.  Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Mol Ther Nucleic Acids       Date:  2014-06-17       Impact factor: 10.183

Review 10.  Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expression.

Authors:  Vaishali Kashyap; Benjamin Bonavida
Journal:  Genes Cancer       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.